The pharmacotherapy of septic shock.
Septic shock is a common clinical problem in the intensive care setting. The high mortality rate associated with septic shock, regardless of age, reflects the inadequacy of available therapeutic approaches. The purpose of this article is to review the current pharmacologic approaches to the treatment of septic shock with an emphasis on the pathophysiologic correlations of these treatments.
Boyd
J L
JL
Department of Anaesthesia, Children's Hospital/Harvard Medical School, Boston, Massachusetts.
Stanford
G G
GG
Chernow
B
B
D000322:Adrenergic Agonists / Q000627:therapeutic use; D000676:Amrinone / Q000627:therapeutic use; D005934:Glucagon / Q000627:therapeutic use; D006801:Humans; D009270:Naloxone / Q000627:therapeutic use; D012772:Shock, Septic / Q000188:drug therapy* / Q000503:physiopathology
D000322:Adrenergic Agonists; D009270:Naloxone; D005934:Glucagon; D000676:Amrinone